Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/15/2008EP1544199B1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
10/15/2008EP1537081B1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
10/15/2008EP1530572B1 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
10/15/2008EP1490069B1 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1476160B1 Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
10/15/2008EP1471881B1 Use of a compound inactivating the kinase a protein in a composition containing a cosmetically acceptable medium in order to lighten the skin
10/15/2008EP1466614B1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
10/15/2008EP1465617B1 Process for affecting neurologic progression
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1455802B1 Uses of chitosan oligosaccharides
10/15/2008EP1453798B1 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
10/15/2008EP1446162B1 Combination motif immune stimulatory oligonucleotides with improved activity
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1432379B1 Methods for inhibiting cognitive deterioration in adults with down's syndrome
10/15/2008EP1429712B1 Method for treating bronchial constriction and bronchospasm
10/15/2008EP1427409B1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
10/15/2008EP1426355B1 Crystals of hydroxynorephedrine derivative
10/15/2008EP1414421B1 The treatment of lipodystrophy with inhibitors of the renin angiotensin system
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/15/2008EP1409492B1 An improved method for preparation of cefuroxime axetil
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1383503B1 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
10/15/2008EP1383497B1 Carbonic anhydrase activators for enhancing learning and memory
10/15/2008EP1379207A4 Composition for freshening nostrils and sinus cavities
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1319008B1 Water soluble rapamycin esters
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1296995B1 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1200129B1 Taste masking of oral quinolone liquid preparations using ion exchange resins
10/15/2008EP1173432B9 Piperidine-indole compounds having 5-ht6 affinity
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008EP1126826B1 Multiparticulate modified release composition of methylphenidate
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008EP0870036B1 Synthetic mammalian alpha-n-acetylglucosaminidase and genetic sequences encoding same
10/15/2008EP0841946B2 Methods for treatment of allergic asthma
10/15/2008EP0363415B1 Compounds for the treatment of alzheimer's disease
10/15/2008CN101287744A Antiviral compounds
10/15/2008CN101287741A Heterobifunctional pan-selectin inhibitors
10/15/2008CN101287738A Imidazo benzodiazepine derivatives
10/15/2008CN101287737A Pentacyclic kinase inhibitors
10/15/2008CN101287736A Pyrrolopyrimidine derivatives as SYK inhibitors
10/15/2008CN101287735A Inhibitors of the HIV integrase enzyme
10/15/2008CN101287734A 2-氨基-7,8-二氢-6H-吡啶并[4,3-d]嘧啶-5-酮 2-amino-7,8-dihydro--6H- pyrido [4,3-d] pyrimidin-5-one
10/15/2008CN101287733A Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities
10/15/2008CN101287732A Modulators of cystic fibrosis transmembrane conductance regulator
10/15/2008CN101287730A Glucuronate salt of a piperazine compound
10/15/2008CN101287729A GPCR agonists
10/15/2008CN101287728A Novel high affinity thiophene-based and furan-based kinase ligands
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287725A DNA-PK inhibitors
10/15/2008CN101287724A Solid salt forms of a pyrrole substituted 2-indolinone
10/15/2008CN101287723A Amide alkyl pyridiyl quinolines as nk3 receptor modulators
10/15/2008CN101287722A Substituted piperazines as metabotropic glutamate receptor antagonists
10/15/2008CN101287719A Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
10/15/2008CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds
10/15/2008CN101287717A Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
10/15/2008CN101287716A Aminodiazepines as toll-like receptor modulators
10/15/2008CN101287714A Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist
10/15/2008CN101287712A Heterocyclic compounds
10/15/2008CN101287708A Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
10/15/2008CN101287707A 激酶抑制剂 Kinase inhibitors
10/15/2008CN101287706A Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
10/15/2008CN101287521A Medical composition suitable for curing malarial in one day time
10/15/2008CN101287507A Methods and devices for lymphatic targeting
10/15/2008CN101287499A Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutical effective lipids
10/15/2008CN101287496A Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
10/15/2008CN101287495A Direct compression formulation of DPP-IV inhibitors and glitazones, and process
10/15/2008CN101287493A Therapy with cd4 binding peptides and radiation
10/15/2008CN101287486A Method of improving learning and memory in mammals
10/15/2008CN101287483A Pharmaceutical compositions and methods for accelerating wound healing
10/15/2008CN101287475A Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
10/15/2008CN101287474A Therapeutic protocols using hyaluronan
10/15/2008CN101287473A Agent for applying to mucosa and method for production thereof
10/15/2008CN101287472A Antiviral 4'-substituted pre-nucleotide phosphoramidates
10/15/2008CN101287471A Methods and compositions for improving recombinant protein production
10/15/2008CN101287470A Improved testosterone gel and method of use
10/15/2008CN101287469A Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine
10/15/2008CN101287468A Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds
10/15/2008CN101287467A Methods and formulations for modulating Lyn kinase activity and treating related disorders
10/15/2008CN101287466A Immediate release therapeutic systems for improved oral absorption of 7-[(E)-t-butyloxyminomethyl] camptothecin
10/15/2008CN101287465A Use of bipyridine compound 'caerulomycin A' derivatives and analogs thereof as immunosuppressive agents
10/15/2008CN101287464A Composition and methods for stimulating gastrointestinal motility
10/15/2008CN101287463A New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders
10/15/2008CN101287462A 治疗疾病的疗法 Treatment of disease therapies
10/15/2008CN101287461A Use of 5-amido-1h-pyrrole-2-nitrile derivative as progesterone receptor modulators
10/15/2008CN101287460A Methods and compositions for the preventioin and treatment of kidney disease
10/15/2008CN101287459A Carbamate compounds for use in treating neurodegenerative disorders
10/15/2008CN101287458A Composition for use in prevention of hypoglycemic condition
10/15/2008CN101287457A Use of treprostinil to treat neuropathic diabetic foot ulcers
10/15/2008CN101287456A Diphenylurea derivatives useful as potassium channel activators
10/15/2008CN101287455A Skin enrichment using CoQ10 as the delivery system
10/15/2008CN101287454A Iontophoresis preparation for treatment of breast cancer and/or mastitis
10/15/2008CN101287452A Solid pharmaceutical compositions comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl) phthalazine and a ph modifier
10/15/2008CN101287451A Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
1 ... 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 ... 7860